Acute myeloid leukemia: therapeutic indications

被引：11

作者：

Burnett, AK ^{[1
]}

Kell, J ^{[1
]}

Rowntree, C ^{[1
]}

机构：

[1] Cardiff Univ, Dept Haematol, Cardiff CF14 4XN, S Glam, Wales

来源：

CURRENT OPINION IN HEMATOLOGY | 2000年 / 7卷 / 06期

关键词：

D O I：

10.1097/00062752-200011000-00002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The main issue for younger patients with acute myeloid leukemia is the prevention of relapse. About 55% of patients relapse and the risk can partially be predicted by prognostic factors, particularly cytogenetics. A number of strategies can attempt to reduce the relapse risk, Intensification of induction therapy has been attempted but there is as yet no convincing evidence that survival is improved. Transplantation of either allogeneic or autologous stem cells does not seem to offer major survival advantage overall or within risk groups. Improved understanding of resistance mechanisms and the identification of new risk factors may enable the development of a more targeted approach to therapy. Curr Opin Hematol 2000, 7:333-338 (C) 2000 Lippincott Williams & Wilkins, Inc.

引用

页码：333 / 338

页数：6

共 44 条

[1] Donor lymphocyte infusion induced molecular remission in relapse of acute myeloid leukaemia after allogeneic bone marrow transplantation [J].

Au, WY ;

Lie, AKW ;

Lee, CK ;

Liang, R ;

Kwong, YL .

BONE MARROW TRANSPLANTATION, 1999, 23 (11) :1201-1203

[2] Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22) [J].

Baer, MR ;

Stewart, CC ;

Lawrence, D ;

Arthur, DC ;

Byrd, JC ;

Davey, FR ;

Schiffer, CA ;

Bloomfield, CD .

BLOOD, 1997, 90 (04) :1643-1648

[3] A randomized study of high-dose cytarabine in induction in acute myeloid leukemia [J].

Bishop, JF ;

Matthews, JP ;

Young, GA ;

Szer, J ;

Gillett, A ;

Joshua, D ;

Bradstock, K ;

Enno, A ;

Wolf, MM ;

Fox, R ;

Cobcroft, R ;

Herrmann, R ;

VanDerWeyden, M ;

Lowenthal, RM ;

Page, F ;

Garson, OM ;

Juneja, S .

BLOOD, 1996, 87 (05) :1710-1717

[4]

Bloomfield CD, 1998, CANCER RES, V58, P4173

[5]

Büchner T, 1999, BLOOD, V93, P4116

[6] Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid:: Result of the randomized MRC trial [J].

Burnett, AK ;

Grimwade, D ;

Solomon, E ;

Wheatley, K ;

Goldstone, AH .

BLOOD, 1999, 93 (12) :4131-4143

[7] Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial [J].

Burnett, AK ;

Goldstone, AH ;

Stevens, RMF ;

Hann, IM ;

Rees, JKH ;

Gray, RG ;

Wheatley, K .

LANCET, 1998, 351 (9104) :700-708

[8]

Burnett AK, 1999, BRIT J HAEMATOL, V105, P67

[9]

BURNETT AK, 1994, BLOOD, V84, pA252

[10]

BURNETT AK, 1999, BR J HAEMATOL S1, V105, pA67

← 1 2 3 4 5 →